Choosing the Right CD34+ Cells Product: Optimize Your Research Potential with Mobilized Stem Cells



January 16, 2024

  • Share
  • The therapeutic potential of CD34+ cells is virtually limitless, but the cells themselves can be obtained through several different formats, such as mobilized leukopaks, bone marrow aspirate and cord blood, or isolated CD34+. So how do you choose which CD34+ cells product is right for your needs? Mobilized peripheral blood yields significantly more enriched CD34+ hematopoetic stem cells from a single donor when compared to non-mobilized leukpaharesis product. With five mobilization regimens to choose from—BioIVT’s expertise in mobilized apheresis collections enables smarter science by providing immediate access to a large global network of highly characterized donors. Whether it’s from mobilized leukopaks, bone marrow aspirate, or isolated cells – BioIVT has your CD34+ needs covered.

    Cancer ResearchCell ScienceImmunologyPersonalized Medicine

    Keep up to date with all your favourite videos and channels.

    Get personalised notifications on new releases and channel content by subscribing to the LabTube eNewsletter.